Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 29;10(12):e0145535.
doi: 10.1371/journal.pone.0145535. eCollection 2015.

Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012)

Nuria Muñoz-Rivas  1 , Manuel Méndez-Bailón  2 , Valentín Hernández-Barrera  3 , José Ma de Miguel-Yanes  4 , Rodrigo Jiménez-García  3 , Jesús Esteban-Hernández  3 , Isabel Jiménez-Trujillo  3 , Alejandro Alvaro-Meca  3 , Pilar Carrasco-Garrido  3 , Javier de Miguel-Díez  5 , Ana López-de-Andrés  3
Affiliations

Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012)

Nuria Muñoz-Rivas et al. PLoS One. .

Erratum in

Abstract

Background: Type 2 Diabetes (T2DM) is the most rapidly increasing risk factor for ischemic stroke. We aimed to compare trends in outcomes for ischemic stroke in people with or without diabetes in Spain between 2003 and 2012.

Methods: We selected all patients hospitalized for ischemic stroke using national hospital discharge data. We evaluated annual incident rates stratified by T2DM status. We analyzed trends in the use of diagnostic and therapeutic procedures, patient comorbidities, and in-hospital outcomes. We calculated in-hospital mortality (IHM), length of hospital stay (LOHS) and readmission rate in one month after discharge. Time trend on the incidence of hospitalization was estimated fitting Poisson regression models by sex and diabetes variables. In-hospital mortality was analyzed using logistic regression models separate for men and women. LOHS were compared with ANOVA or Kruskal-Wallis when necessary.

Results: We identified a total of 423,475 discharges of patients (221,418 men and 202,057 women) admitted with ischemic stroke as primary diagnosis. Patients with T2DM accounted for 30.9% of total. The estimated incidence rates of discharges increased significantly in all groups. The incidence of hospitalization due to stroke (with ICD9 codes for stroke as main diagnosis at discharge) was higher among those with than those without diabetes in all the years studied. T2DM was positively associated with ischemic stroke with an adjusted incidence rate ratio (IRR) of 2.27 (95% CI 2.24-2.29) for men and 2.15 (95%CI 2.13-2.17) for women. Over the 10 year period LOHS decreased significantly in men and women with and without diabetes. Readmission rate remained stable in diabetic and non diabetic men (around 5%) while slightly increased in women with and without diabetes. We observed a significant increase in the use of fibrinolysis from 2002-2013. IHM was positively associated with older age in all groups, with Charlson Comorbidity Index > 3 and atrial fibrillation as risk factors. The IHM did not change significantly over time among T2DM men and women ranging from 9.25% to 10.56% and from 13.21% to 14.86%, respectively; neither did among non-diabetic women. However, in men without T2DM IHM decreased significantly over time. Diabetes was associated to higher IHM only in women (OR 1.07; 95% CI, 1.05-1.11).

Conclusions: Our national data show that incidence rate of ischemic stroke hospitalization increased significantly during the period of study (2003-2012). People with T2DM have more than double the risk of ischemic stroke after adjusting for other risk factors. Women with T2DM had poorer outcomes- IHM and readmission rates- than diabetic men. Diabetes was an independent factor for IHM only in women.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have the following interests: This study was partly funded by URJC-Banco Santander to the Grupo de Excelencia Investigadora ITPSE (Grant N°30VCPIGI03). There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

References

    1. Bejot Y, Benatru I, Rouaud O, Fromont A, Besancenot JP, Moreau T, et al.:. Epidemiology of stroke in Europe: geographic and environmental differences. J Neurol Sci 2007; 262:85–88. - PubMed
    1. López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757. - PubMed
    1. Grysiewicz RA, Thomas K, Pandey DK:. Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors. Neurol Clin. 2008; 26: 871–895. 10.1016/j.ncl.2008.07.003 - DOI - PubMed
    1. Luitse MJ, Biessels GJ, Rutten G E, Kappelle LJ: Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11:261–271. 10.1016/S1474-4422(12)70005-4 - DOI - PubMed
    1. Idris I, Thomson GA, Sharma JC: Diabetes mellitus and stroke. Int J Clin Pract 2006; 60: 48–56. - PubMed

Publication types